Target Selectivity of EPZ-6438 (Tazemetostat)
| Key Target | IC50 | Description | Reference |
|---|---|---|---|
| EZH2 | 0.697 nM | -- | PMC10895674 |
| EZH2 | 10 μM | cell proliferation | PMC11718850 |
Check the
EPZ-6438 (Tazemetostat)
product page for in-depth specifications, including solubility, stock solutions, MOA, and working concentrations.
Jump to
- EPZ-6438 (Tazemetostat) Mechanism of Action: EZH2 Inhibition in B-Cell Research
- EPZ-6438 (Tazemetostat) Clinical Trials
- EPZ-6438 (Tazemetostat) Working Concentration | Cell Culture | Treatment
- EPZ-6438 (Tazemetostat) Solubility in DMSO
- EPZ-6438 (Tazemetostat) Stock Solution
- EPZ-6438 (Tazemetostat) Storage
- EPZ-6438 (Tazemetostat) Stability
- EPZ-6438 (Tazemetostat) VS GSK126 | 3-Deazaneplanocin A (DZNep) Hydrochloride
- EPZ-6438 (Tazemetostat) Molecular Weight
- EPZ-6438 (Tazemetostat) SMILES
- EPZ-6438 (Tazemetostat) CAS Number
- EPZ-6438 (Tazemetostat) Chemical Structure (2D and 3D)
- EPZ-6438 (Tazemetostat) IC50 for Cell-based and Cell-free Assays
- EPZ-6438 (Tazemetostat) Sigma (SBR00098)? Try a better option.
- EPZ-6438 (Tazemetostat) MedChemExpress (HY-13803)? Try a better option.
- EPZ-6438 (Tazemetostat) Cayman (16174)? Try a better option.
- EPZ-6438 (Tazemetostat) Tocris (8093)? Try a better option.
- EPZ-6438 (Tazemetostat) TargetMol (T1788)? Try a better option.
- EPZ-6438 (Tazemetostat) SDS｜MSDS